Clinical Trial Detail

NCT ID NCT02867618
Title Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Changchun Deng
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

CLL/SLL

Therapies

Carfilzomib + Umbralisib

Age Groups: adult senior

No variant requirements are available.